Cargando…
Clinical significance of EPHX2 deregulation in prostate cancer
The arachidonic acid (AA) metabolic pathway participates in various physiological processes as well as in the development of malignancies. We analyzed genomic alterations in AA metabolic enzymes in the Cancer Genome Atlas (TCGA) prostate cancer (PCa) dataset and found that the gene encoding soluble...
Autores principales: | Liu, Ming-Sheng, Zhao, Hui, Xu, Chen-Xiang, Xie, Ping-Bo, Wang, Wei, Yang, Ying-Yu, Lee, Wen-Hui, Jin, Yang, Zhou, Hong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831821/ https://www.ncbi.nlm.nih.gov/pubmed/32687069 http://dx.doi.org/10.4103/aja.aja_34_20 |
Ejemplares similares
-
Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and Colorectal Cancer Risk
por: Liu, Fei, et al.
Publicado: (2012) -
Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma
por: Zhan, Ke, et al.
Publicado: (2021) -
Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease
por: Reisdorf, William C., et al.
Publicado: (2019) -
The effect on congenital heart diseases of maternal EPHX1 polymorphisms modified by polycyclic aromatic hydrocarbons exposure
por: Tao, Jing, et al.
Publicado: (2019) -
Quantitative Methylation Level of the EPHX1 Promoter in Peripheral Blood DNA Is Associated with Polycystic Ovary Syndrome
por: Sang, Qing, et al.
Publicado: (2014)